Patent application number | Description | Published |
20100306328 | METHOD FOR TRANSMITTING A COMMUNICATION INVITATION RELATING TO A MEDICAL DICOM IMAGE - A method for transmitting an invitation to a communication relating to a medical image in a DICOM data record from a person who has access to the image to a partner is proposed. The invitation is stored as information in the DICOM data record of the image. The DICOM data record is transmitted to a server. With reference to the invitation, the server determines a message channel which leads to the partner. The server transmits the invitation to the partner via the message channel. | 12-02-2010 |
20110202176 | Method for Operating a Multi-Axis Robot - A method for operating a multi-axis, preferably six-axis, robot with axes that can be driven by drive means is proposed. The axes are possible to be moved separately and their movement is controlled by a control facility. Before the movement of the robot is executed, a control data record is created for controlling the movement of the robot as a function of initial and target information for the robot input by a user. The control facility performs a verification of the control data record in respect of at least one predefined basic condition relating to the operation of the robot stored in a memory. The control data record is adjusted based on the at least one basic condition whilst retaining the target information as a function of the result of the check. | 08-18-2011 |
20110282193 | METHOD AND APPARATUS FOR SELECTIVE INTERNAL RADIATION THERAPY PLANNING AND IMPLEMENTATION - In a method and system for planning and implementing a selective internal radiation therapy (SIRT), the liver volume and the tumor volume are automatically calculated in a processor by analysis of items segmented from images obtained from the patient using one or more imaging modalities, with the administration of contrast agent. In the processor, the volume of therapeutic agent that is necessary to treat the tumor is automatically calculated from the liver volume, the tumor volume, and the body surface area of the patient and the lung shunt percentage for the patient. The segmented tumor, as well as segmented feeder vessels are overlaid on a live fluoroscopic image of the patient during SIRT, to assist in positioning a catheter for administering the therapeutic agent, which is then administered according to the calculated volume. The therapeutic agent can be administered via respective feeder vessels in respectively different amounts that correspond to the percentage of blood supply to the tumor from the respective feeder vessels, this distribution also being automatically calculated by analysis of one or more parenchymal blood volume (PBV) images. | 11-17-2011 |
20130261431 | PAE TREATMENT FOR BPH - A method of guiding a catheter during an embolization operation includes receiving volume data of a patient volume, the patient volume including a lesion and a feeding vessel for the lesion, detecting the feeding vessel in the volume data, define a vessel connection path for the feeding vessel, the vessel connection path connecting first and second points in the volume data, the second point being disposed along the feeding vessel, receiving fluoroscopic projection data of the patient volume, and rendering the fluoroscopic projection data with an overlay during the embolization operation, the overlay including the vessel connection path for the feeding vessel. | 10-03-2013 |
20140294155 | RADIOGRAPHY DEVICE AND METHOD FOR EXAMINATIONS IN THE FIELD OF PEDIATRIC RADIOLOGY - A radiography device and a radiography method are specifically adapted for examinations in the field of pediatric radiology. The radiography device examines a diagnosis-relevant region of a patient. The device has a radiation source, which emits radiological rays in an irradiation direction. An irradiation surface is selectable in dependence of a specified examination region of the patient. The radiography device also has a measurement field. The size of the measurement field is changeable such that the size of the measurement field and the size of the irradiation surface correlate. | 10-02-2014 |
Patent application number | Description | Published |
20110135320 | TECHNIQUE FOR CALIBRATING AND CENTERING AN OPTICAL RECEIVER - A technique for calibrating an optical receiver is described. During this technique, a front-end circuit in the optical receiver receives an optical signal that corresponds to a sequence with alternating groups of symbol types that correspond to binary values, where durations of the groups of a given symbol type, which can correspond to a first binary value or a second binary value, progressively decrease during the sequence. Then, the output of the feedback circuit is adjusted based at least on the sequence. When the durations of groups corresponding to the first binary value and the second binary value reach their minimum values in the sequence, a calibration value corresponding to the output of the feedback circuit is stored for use during a normal operating mode of the optical receiver. | 06-09-2011 |
20140052713 | HARDWARE IMPLEMENTATION OF THE AGGREGATION/GROUP BY OPERATION: FILTER METHOD - Techniques are described for performing grouping and aggregation operations. In an embodiment, a request is received to aggregate data grouped by a first column. In response to receiving the request, values are loaded from the first column into an input cache. The values include values, from the first column, from a set of rows. A filter unit is programmed with logic to perform a comparison between a particular value, from the first column of a first row, and values in the first column of a plurality of rows, of the set of rows. Based on the comparison, a predicate result is generated that identifies rows, within the plurality of rows, that have a valued in the first column that matches the particular value. An aggregate value for a second column is generated by aggregating values, from the second column, of each of the rows identified by the predicate result. | 02-20-2014 |
20140052726 | HARDWARE IMPLEMENTATION OF THE AGGREGATION/GROUP BY OPERATION: HASH-TABLE METHOD - Techniques are described for performing grouping and aggregation operations. In one embodiment, a request is received to aggregate data grouped by a first column. In response to receiving the request, a group value in a row of a first column is mapped to an address. A pointer is stored for a first group at a first location identified by the address. The pointer identifies a second location of a set of aggregation data for the first group. An aggregate value included in the set of aggregation data is updated based on a value in the row of a second column. | 02-20-2014 |
20140052743 | HARDWARE IMPLEMENTATION OF THE FILTER/PROJECT OPERATIONS - Techniques are described for performing filter and project operations. In an embodiment, a set of predicates that specify criteria for filtering results to a query is received. Based on a particular predicate of the set of predicates, a predicate result for at least one portion of a particular column is generated. The predicate result identifies rows within the first column that satisfy the particular predicate. Rows are selected and returned as results to the query based at least in part on the predicate result. In an embodiment, the predicate result is a bitvector where each bit of the bitvector corresponds to a particular row within the particular column and identify whether the particular row satisfies the particular predicate. | 02-20-2014 |
20140185352 | CONFIGURABLE-WIDTH MEMORY CHANNELS FOR STACKED MEMORY STRUCTURES - The disclosed embodiments provide a chip package that facilitates configurable-width memory channels. In this chip package, a semiconductor die is electrically connected to two or more memory chips. More specifically, contacts on each individual memory chip are each directly connected to a distinct set of contacts on the semiconductor die such that the semiconductor die has separate, unique command and address buses to individually address and communicate with each individual memory chip. Individually addressable memory chips that are each accessed via separate command and address buses facilitate a configurable-width memory channel that efficiently supports different data-access granularities. | 07-03-2014 |
20150071021 | ACCESSING INDEPENDENTLY ADDRESSABLE MEMORY CHIPS - A method of accessing rows and columns stored in a memory system that include memory chips that can be individually addressed and accessed is described. In order to leverage this capability, prior to performing a row-write request on the memory system, a computer system may transform the rows and the columns in a matrix. In particular, in response to receiving a row-write request to write to a row N in the matrix, the computer system rotates the row right by N elements, and writes the row in parallel to address N of the memory chips in the memory system. Similarly, in response to receiving a column-write request to write to column M in the matrix, the computer system rotates the column right by M elements, and writes the column in parallel to the memory chips in the memory system. | 03-12-2015 |
20150160482 | WAVELENGTH-LOCKING A RING-RESONATOR MODULATOR - In the optical device, a ring-resonator modulator, having an adjustable resonance (center) wavelength, optically couples an optical signal that includes the carrier wavelength from an input optical waveguide to an output optical waveguide. A monitoring mechanism in the optical device, which is optically coupled to the output optical waveguide, monitors a performance metric of an output optical signal from the output waveguide. For example, the monitoring mechanism may monitor: an average optical power associated with the output optical signal, and/or an amplitude of the output optical signal. Moreover, control logic in the optical device adjusts the resonance wavelength based on the monitored performance metric so that the performance metric is optimized. | 06-11-2015 |
Patent application number | Description | Published |
20080300265 | ANTIVIRAL DRUGS FOR TREATMENT OF ARENAVRUS INFECTION - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, Pichinde, and LCMV), Filoviridae (Ebola and Marburg viruses), Flaviviridae (yellow fever, Omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever and Crimean-Congo hemorrhagic fever). | 12-04-2008 |
20090036513 | Antiviral Drugs for Treatment of Arenavirus Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, and Pichinde), Filoviridae (Ebola and Marburg viruses), Flaviviridae (yellow fever, Omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever). | 02-05-2009 |
20120149751 | Antiviral Drugs for Treatment of Arenavirus Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, and Pichinde), Filoviridae (Ebola and Marburg viruses), Flaviviridae (yellow fever, Omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever). | 06-14-2012 |
Patent application number | Description | Published |
20110027227 | ANTIVIRAL DRUGS FOR TREATMENT OF ARENAVIRUS INFECTION - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by the Arenavirus family is disclosed. | 02-03-2011 |
20110064693 | Antiviral Drugs for Treatment of Arenavirus Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by the Arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian hemorrhagic fever, and Venezuelan hemorrhagic fever. | 03-17-2011 |
20110172281 | Anti-Viral Drugs for Treatment of Arenavirus Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, Pichinde, and LCMV), Filoviridae (Ebola and Marburg viruses), Flaviviridae (yellow fever, Omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever). | 07-14-2011 |
20120022027 | SULFONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENAVIRUSES - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel semicarbazides, sulfonyl carbazides, ureas and related compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to Arenaviridae (Junin, Machupo, Guanavito, Sabia and Lassa), Filoviridae (ebola and Marburg viruses), Flaviviridae (yellow fever, omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever). | 01-26-2012 |
20120071447 | Antiviral Drugs for Treatment of Arenavirus Infection - Methods, compounds, and pharmaceutical compositions for treating an arenavirus infections are disclosed. Methods for preparing the compounds and pharmaceutical compositions are also disclosed. | 03-22-2012 |
20120308519 | Anti-Arenaviral Compounds - Described herein are 4-methyl-piperazine-1-carbothioic acid amide derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases caused by hemorrhagic fever viruses, such as Arenaviruses. | 12-06-2012 |
20130165493 | Antiviral Drugs for Treatment of Arenavirus Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to, Arenaviridae (Junin, Machupo, Guanarito, Sabia, Lassa, Tacaribe, and Pichinde), Filoviridae (Ebola and Marburg viruses), Flaviviridae (yellow fever, Omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever). | 06-27-2013 |
20130195796 | Inhibitors and Methods of Inhibiting Bacterial and Viral Pathogens - Compounds, pharmaceutical compositions and methods for treating viral and bacterial infections, by administering certain thiourea compounds, specifically acylthiourea, carboximidoylthiourea and S-alkyl isothiourea derivatives and analogs, in therapeutically effective amounts are disclosed. | 08-01-2013 |
20140100245 | Antiviral Drugs for Treatment of Arenvirus Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by the | 04-10-2014 |
20140128426 | Antiviral Drugs for Treatment of Arenavirus Infection - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by the | 05-08-2014 |
20140243367 | ANTIVIRAL DRUGS FOR TREATMENT OF ARENAVIRUS INFECTION - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by the Arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian hemorrhagic fever, and Venezuelan hemorrhagic fever. | 08-28-2014 |
20140301979 | ANTI-ARENAVIRAL COMPOUNDS - Described herein are 4-methyl-piperazine-1-carbothioic acid amide derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases caused by hemorrhagic fever viruses, such as Arenaviruses. | 10-09-2014 |
20140378681 | SULFONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS,PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENAVIRUSES - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain novel semicarbazides, sulfonyl carbazides, ureas and related compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by hemorrhagic fever viruses is disclosed, i.e., including but not limited to Arenaviridae (Junin, Machupo, Guanavito, Sabia and Lassa), Filoviridae (ebola and Marburg viruses), Flaviviridae (yellow fever, omsk hemorrhagic fever and Kyasanur Forest disease viruses), and Bunyaviridae (Rift Valley fever). | 12-25-2014 |
20150023916 | ANTIVIRAL DRUGS FOR TREATMENT OF ARENAVIRUS INFECTION - Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by the Arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian hemorrhagic fever, and Venezuelan hemorrhagic fever. | 01-22-2015 |
20160081950 | INHIBITORS AND METHODS OF INHIBITING BACTERIAL AND VIRAL PATHOGENS - Compounds, pharmaceutical compositions and methods for treating viral and bacterial infections, by administering certain thiourea compounds, specifically acylthiourea, carboximidoylthiourea and S-alkyl isothiourea derivatives and analogs, in therapeutically effective amounts are disclosed. | 03-24-2016 |